Clinical Research on Bowel Symptoms of Patient With Pelvic Organ Prolapse

May 26, 2021 updated by: Tan Cheng, Peking University People's Hospital

Clinical Research on Bowel Symptoms of Patients With Pelvic Organ Prolapse

To study the prevalence of bowel symptoms in patients with pelvic organ prolapse.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100044
        • Recruiting
        • Peking University People's Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • The patients with stage>2 POP are recruited.The patients are all received surgeries, which include transvaginal synthetic mesh surgery, the sacral fixation, tissue repair surgery and colpocleisis.

Exclusion Criteria:

  • Gestation;
  • Inflammatory bowel disease;
  • Slow transit constipation diagnosed by Colonic transit test;
  • Unable to follow up.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mesh repairment
patients undergoing pelvic floor Reconstruction using mesh
Active Comparator: Tradition Neoplasty
patients undergoing traditional surgical approaches

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in the prevalence of bowel symptoms
Time Frame: baseline,1,3,6,12 months after operation.
baseline,1,3,6,12 months after operation.
change in the severity of intestinal symptoms
Time Frame: baseline,1,3,6,12 months after operation.
assessed by Birmingham Bowel and Urinary Symptoms Questionnaire
baseline,1,3,6,12 months after operation.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in the quality of life
Time Frame: baseline,1,3,6,12 months after operation.
assessed by international consultation on incontinence questionnaire short form
baseline,1,3,6,12 months after operation.
length of the high-pressure zone recorded by anorectal manometry
Time Frame: baseline and 12 months after operation
baseline and 12 months after operation
rectoanal inhibitory reflex recorded by anorectal manometry
Time Frame: baseline and 12 months after operation
baseline and 12 months after operation
Rectal-Vaginal pressure interval during maximum Vasalva
Time Frame: baseline and 6 months after operation
Measured by Peritron manometer
baseline and 6 months after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2016

Primary Completion (Anticipated)

April 1, 2022

Study Completion (Anticipated)

May 1, 2022

Study Registration Dates

First Submitted

January 28, 2016

First Submitted That Met QC Criteria

April 1, 2016

First Posted (Estimate)

April 7, 2016

Study Record Updates

Last Update Posted (Actual)

May 28, 2021

Last Update Submitted That Met QC Criteria

May 26, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • pkuph-0103969

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bowel Symptoms

Clinical Trials on Pelvic floor reconstruction(with or without mesh)

3
Subscribe